Tourmaline Bio (TRML) Stock Chart & Stock Price History → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free TRML Stock Alerts $13.77 +0.25 (+1.85%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tourmaline Bio Stock Price Performance5 Day Performance+2.38%1 Month Performance-12.35%3 Month Performance-67.67%6 Month Performance-27.53%Year-To-Date Performance-47.40% Receive TRML Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. TRML Stock Chart for Saturday, June, 1, 2024 TRML Chart by TradingView Tourmaline Bio Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$13.52$13.77+1.85%$14.00$13.50273,358 shs$353.20 million05/30/2024$13.61$13.52-0.66%$13.80$13.38695,067 shs$346.79 million05/29/2024$13.70$13.61-0.66%$13.92$13.47273,046 shs$349.10 million05/28/2024$13.45$13.70+1.86%$13.86$13.19430,498 shs$351.41 million05/27/2024$13.45$13.45$13.88$13.41326,900 shs$344.95 million05/24/2024$13.66$13.45-1.54%$13.88$13.41326,663 shs$344.99 million Get the Latest News and Ratings for TRML and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$13.63$13.66+0.22%$13.83$13.17340,784 shs$350.38 million05/22/2024$14.03$13.63-2.85%$14.20$13.54186,563 shs$349.61 million05/21/2024$14.56$14.03-3.64%$14.50$13.75247,079 shs$359.87 million05/20/2024$15.04$14.56-3.19%$15.05$14.38172,500 shs$373.46 million05/17/2024$15.00$15.04+0.27%$15.45$14.64184,978 shs$385.78 million05/16/2024$15.25$15.00-1.64%$15.78$14.96213,469 shs$384.75 million05/15/2024$14.42$15.25+5.76%$15.89$14.63178,325 shs$391.16 million05/14/2024$14.44$14.42-0.14%$14.95$14.36380,393 shs$369.87 million05/13/2024$14.50$14.44-0.41%$15.25$14.26270,951 shs$370.34 million05/10/2024$15.77$14.50-8.05%$15.87$14.33261,699 shs$371.88 million05/09/2024$15.55$15.77+1.41%$15.95$15.42231,805 shs$404.45 million05/08/2024$15.78$15.55-1.46%$15.89$15.30193,744 shs$398.81 million05/07/2024$15.53$15.78+1.61%$15.97$15.31226,332 shs$404.76 million05/06/2024$15.84$15.53-1.96%$16.11$15.35224,061 shs$398.34 million05/03/2024$15.92$15.84-0.50%$16.50$15.73190,613 shs$406.30 million05/02/2024$15.71$15.92+1.34%$16.36$15.69469,896 shs$408.35 million05/01/2024$15.83$15.71-0.76%$16.58$15.57303,988 shs$402.96 million04/30/2024$15.50$15.83+2.13%$15.83$15.14249,596 shs$406.04 million04/29/2024$15.68$15.50-1.15%$16.40$15.30233,734 shs$397.58 million04/26/2024$16.00$15.68-2.00%$16.34$15.59360,149 shs$402.19 million04/25/2024$15.41$16.00+3.83%$16.10$14.70448,811 shs$410.40 million04/24/2024$15.09$15.41+2.12%$16.06$14.961.78 million shs$395.27 million04/23/2024$15.50$15.09-2.65%$15.86$15.04374,105 shs$387.06 million04/22/2024$15.45$15.50+0.32%$16.37$15.37754,764 shs$397.58 million04/19/2024$15.66$15.45-1.34%$16.01$15.13737,656 shs$396.25 million04/18/2024$16.68$15.66-6.12%$16.66$15.61547,179 shs$401.68 million04/17/2024$17.86$16.68-6.61%$17.94$16.30591,856 shs$427.84 million04/16/2024$18.99$17.86-5.95%$19.31$17.67348,601 shs$458.11 million04/15/2024$20.15$18.99-5.76%$20.65$18.82333,583 shs$487.09 million04/12/2024$20.10$20.15+0.25%$21.07$19.42312,706 shs$516.85 million04/11/2024$19.91$20.10+0.95%$20.51$19.69221,065 shs$515.57 million04/10/2024$22.89$19.91-13.02%$22.85$19.79550,531 shs$510.69 million04/09/2024$23.09$22.89-0.87%$23.18$22.20173,418 shs$587.13 million04/08/2024$22.61$23.09+2.12%$23.70$22.00213,172 shs$592.26 millionDon’t buy a single NVIDIA share before you see this... (Ad)If you feel like NVIDIA is still a good buy - be careful. Billionaires like Steve Cohen, Stanley Druckenmiller and George Soros are ALL dumping NVIDIA... And piling into an overlooked sector...I've prepared a short briefing with all the proof04/05/2024$21.96$22.61+2.96%$22.66$21.22211,255 shs$579.95 million04/04/2024$21.90$21.96+0.27%$22.70$21.82177,250 shs$563.27 million04/03/2024$21.80$21.90+0.46%$22.85$21.00189,906 shs$561.74 million04/02/2024$23.54$21.80-7.39%$23.45$21.18345,081 shs$559.17 million04/01/2024$22.90$23.54+2.79%$23.67$22.40353,844 shs$603.80 million03/29/2024$22.90$22.90$23.87$22.20674,938 shs$465.79 million03/28/2024$22.90$22.90$23.87$22.20674,704 shs$465.79 million03/27/2024$23.82$22.90-3.86%$23.94$22.42581,989 shs$465.79 million03/26/2024$23.81$23.82+0.04%$24.45$22.70426,530 shs$484.50 million03/25/2024$24.67$23.81-3.49%$24.65$23.061.12 million shs$484.30 million03/22/2024$28.61$24.67-13.77%$28.71$23.871.69 million shs$501.79 million03/21/2024$44.67$28.61-35.95%$30.00$25.064.94 million shs$581.93 million03/20/2024$40.33$44.67+10.76%$45.55$41.78339,425 shs$908.50 million03/19/2024$40.01$40.33+0.80%$40.90$38.00279,353 shs$820.31 million03/18/2024$43.19$40.01-7.36%$42.76$39.78133,970 shs$813.80 million03/15/2024$41.72$43.19+3.52%$44.32$41.18308,629 shs$878.40 million03/14/2024$45.39$41.72-8.09%$46.36$40.62128,776 shs$848.59 million03/13/2024$45.64$45.39-0.55%$48.31$44.68270,915 shs$923.23 million03/12/2024$41.76$45.64+9.29%$46.76$41.19254,609 shs$928.32 million03/11/2024$41.78$41.76-0.05%$42.94$40.20297,028 shs$849.40 million03/08/2024$41.32$41.78+1.11%$42.64$40.72230,949 shs$849.81 million03/07/2024$40.30$41.32+2.53%$41.90$40.3852,803 shs$840.45 million03/06/2024$40.14$40.30+0.40%$41.75$39.83142,947 shs$819.70 million03/05/2024$39.75$40.14+0.98%$41.32$39.27100,634 shs$816.45 million03/04/2024$42.59$39.75-6.67%$43.73$38.57146,921 shs$808.52 million03/01/2024$38.82$42.59+9.71%$42.87$38.09339,967 shs$866.20 million02/29/2024$38.50$38.82+0.83%$40.10$38.74407,708 shs$789.60 million Related Companies: Tarsus Pharmaceuticals Stock Price Chart 4D Molecular Therapeutics Stock Price Chart BioCryst Pharmaceuticals Stock Price Chart Autolus Therapeutics Stock Price Chart Immatics Stock Price Chart Mesoblast Stock Price Chart Relay Therapeutics Stock Price Chart Scholar Rock Stock Price Chart Prime Medicine Stock Price Chart CARGO Therapeutics Stock Price Chart Receive TRML Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tourmaline Bio and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRML) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlace“Financial tsunami is coming to America”Porter & CompanyNvidia is about to pass AppleWeiss RatingsUnlock Explosive Gains with This Defense StockBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tourmaline Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.